Dapagliflozin reduces epicardial adipose tissue in patients with heart failure with reduced ejection fraction and type 2 diabetes
Event:
ESC Congress 2024
Topic:
Imaging of Heart Failure
Session:
Myocardial ischaemia and heart failure: insight from multimodality imaging
